Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 July 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 206 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website. 

 

 

Export 15 results:
Author [ Title(Desc)] Type Year
Filters: Author is Logie, J.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
5
P. Boyle, Roehrborn, C., Harkaway, R., Logie, J., de la Rosette, J., and Emberton, M., “5-Alpha reductase inhibition provides superior benefits to alpha blockade by preventing AUR and BPH-related surgery”, Eur Urol, vol. 45, pp. 620-6; discussion 626-7, 2004.
E
C. Cohet, Haguinet, F., G. Santos, D., Webb, D., Logie, J., G. Ferreira, L., Rosillon, D., and Shinde, V., “Effect of the adjuvanted (AS03) A/H1N1 2009 pandemic influenza vaccine on the risk of rejection in solid organ transplant recipients in England: a self-controlled case series”, BMJ Open, vol. 6, p. e009264, 2016.
H
G. Requena, Huerta, C., Gardarsdottir, H., Logie, J., Gonzalez-Gonzalez, R., Abbing-Karahagopian, V., Miret, M., Schneider, C., Souverein, P. C., Webb, D., Afonso, A., Boudiaf, N., Martin, E., Oliva, B., Alvarez, A., de Groot, M. C., Bate, A., Johansson, S., Schlienger, R., Reynolds, R., Klungel, O. H., and de Abajo, F. J., “Hip/femur fractures associated with the use of benzodiazepines (anxiolytics, hypnotics and related drugs): a methodological approach to assess consistencies across databases from the PROTECT-EU project”, Pharmacoepidemiol Drug Saf, vol. 25 Suppl 1, pp. 66-78, 2016.
G. M. Clifford, Logie, J., and Farmer, R. D., “How do symptoms indicative of BPH progress in real life practice? The UK experience”, Eur Urol, vol. 38 Suppl 1, pp. 48-53, 2000.
I
J. Logie, Clifford, G. M., and Farmer, R. D., “Incidence, prevalence and management of lower urinary tract symptoms in men in the UK”, BJU Int, vol. 95, pp. 557-62, 2005.
D. M. Fleming, Taylor, R. J., Haguinet, F., Schuck-Paim, C., Logie, J., Webb, D. J., Lustig, R. L., and Matias, G., “Influenza-attributable burden in United Kingdom primary care”, Epidemiol Infect, vol. 144, pp. 537-47, 2016.
M
S. Taylor, Taylor, R. J., Lustig, R. L., Schuck-Paim, C., Haguinet, F., Webb, D. J., Logie, J., Matias, G., and Fleming, D. M., “Modelling estimates of the burden of respiratory syncytial virus infection in children in the UK”, BMJ Open, vol. 6, p. e009337, 2016.
D. M. Fleming, Taylor, R. J., Lustig, R. L., Schuck-Paim, C., Haguinet, F., Webb, D. J., Logie, J., Matias, G., and Taylor, S., “Modelling estimates of the burden of Respiratory Syncytial virus infection in adults and the elderly in the United Kingdom”, BMC Infect Dis, vol. 15, p. 443, 2015.
N
G. M. Clifford, Logie, J., and Farmer, R. D., “No risk of drug-associated liver injury with alpha1-adrenoreceptor blocking agents in men with BPH: results from an observational study using the GPRD”, Pharmacoepidemiol Drug Saf, vol. 14, pp. 75-80, 2005.
T. Wilke, Mueller, S., Groth, A., Berg, B., Fuchs, A., Sikirica, M., Logie, J., Martin, A., and Maywald, U., “Non-Persistence and Non-Adherence of Patients with Type 2 Diabetes Mellitus in Therapy with GLP-1 Receptor Agonists: A Retrospective Analysis”, Diabetes Ther, vol. 7, pp. 105-24, 2016.
P
B. Ineichen, Logie, J., Rowlands, S., and Lawrenson, R., “Patterns of prescription of PC4 by general practitioners in England and Wales”, Eur J Contracept Reprod Health Care, vol. 5, pp. 241-7, 2000.
R
S. Rowlands, Devalia, H., Lawrenson, R., Logie, J., and Ineichen, B., “Repeated use of hormonal emergency contraception by younger women in the UK”, Br J Fam Plann, vol. 26, pp. 138-43, 2000.
M. C. Irizarry, Webb, D. J., Boudiaf, N., Logie, J., Habel, L. A., Udaltsova, N., and Friedman, G. D., “Risk of cancer in patients exposed to gabapentin in two electronic medical record systems”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 214-25, 2012.
M. A. Feudjo-Tepie, Hall, S. A., Logie, J., and Robinson, N. J., “Risk of cataract among idiopathic thrombocytopenic purpura patients in the UK general practice research database”, Pharmacoepidemiol Drug Saf, vol. 18, pp. 380-5, 2009.
D. G. Santos, Haguinet, F., Cohet, C., Webb, D., Logie, J., Ferreira, G. L., Rosillon, D., and Shinde, V., “Risk of solid organ transplant rejection following vaccination with seasonal trivalent inactivated influenza vaccines in England: A self-controlled case-series”, Vaccine, vol. 34, pp. 3598-606, 2016.
[Page last reviewed 6 July 2020]